Cargando…

Expected motor function change following decompressive surgery for spinal metastatic disease

BACKGROUND: Motor function in patients with spinal metastatic disease (SMD) directly impacts a patient's ability to receive systemic therapy and overall survival. Spine surgeons may be in the challenging position to advise a patient on expected motor function outcomes and determine a patient�...

Descripción completa

Detalles Bibliográficos
Autores principales: Okai, Bernard K., Lipinski, Lindsay J., Ghannam, Moleca M., Fabiano, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345847/
https://www.ncbi.nlm.nih.gov/pubmed/37457395
http://dx.doi.org/10.1016/j.xnsj.2023.100240
_version_ 1785073181291184128
author Okai, Bernard K.
Lipinski, Lindsay J.
Ghannam, Moleca M.
Fabiano, Andrew J.
author_facet Okai, Bernard K.
Lipinski, Lindsay J.
Ghannam, Moleca M.
Fabiano, Andrew J.
author_sort Okai, Bernard K.
collection PubMed
description BACKGROUND: Motor function in patients with spinal metastatic disease (SMD) directly impacts a patient's ability to receive systemic therapy and overall survival. Spine surgeons may be in the challenging position to advise a patient on expected motor function outcomes and determine a patient's suitability as a surgical candidate. We present this study to provide this critical information on anticipated motor function change to spine surgeons. METHODS: Consecutive patients undergoing spinal surgery for SMD at a National Cancer Institute-designated cancer institute were prospectively enrolled. Patient motor function status before and after surgery was assessed using the standard 0 to 5 five-point muscle strength grading scale. The difference in presurgical and postsurgical motor function (proximal and distal) was used to assess motor function changes following surgery. RESULTS: A total of 171 patients were included. The mean age was 62.7±10.46 years and 40.9% (70) were female. Common primary malignancy types were lung (49), kidney (28), breast (25), and prostate (23). The average proximal and distal motor function difference was 0.38 (standard deviation=1.02, p<.0001) and 0.32 (standard deviation=0.91, p<.0001) respectively showing an improvement following surgery. Patients with proximal presurgical motor function of 2, 3, and 4 had an improved motor function in 73%, 77%, and 73% of the patients. Patients with distal presurgical motor function of 2, 3, and 4 had an improved motor function in 80%, 89%, and 70% of the patients. CONCLUSIONS: Most patients undergoing surgery for SMD have a modest improvement in motor function following surgery. The degree of improvement in most instances is less than 1 point on a 0 to 5 motor function scale. This is critical knowledge for a spinal surgeon when evaluating SMD patients with significant preoperative motor function deficits. These results aid spinal surgeons in setting expectations and evaluating the need for rapid spinal decompression.
format Online
Article
Text
id pubmed-10345847
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103458472023-07-15 Expected motor function change following decompressive surgery for spinal metastatic disease Okai, Bernard K. Lipinski, Lindsay J. Ghannam, Moleca M. Fabiano, Andrew J. N Am Spine Soc J Clinical Studies BACKGROUND: Motor function in patients with spinal metastatic disease (SMD) directly impacts a patient's ability to receive systemic therapy and overall survival. Spine surgeons may be in the challenging position to advise a patient on expected motor function outcomes and determine a patient's suitability as a surgical candidate. We present this study to provide this critical information on anticipated motor function change to spine surgeons. METHODS: Consecutive patients undergoing spinal surgery for SMD at a National Cancer Institute-designated cancer institute were prospectively enrolled. Patient motor function status before and after surgery was assessed using the standard 0 to 5 five-point muscle strength grading scale. The difference in presurgical and postsurgical motor function (proximal and distal) was used to assess motor function changes following surgery. RESULTS: A total of 171 patients were included. The mean age was 62.7±10.46 years and 40.9% (70) were female. Common primary malignancy types were lung (49), kidney (28), breast (25), and prostate (23). The average proximal and distal motor function difference was 0.38 (standard deviation=1.02, p<.0001) and 0.32 (standard deviation=0.91, p<.0001) respectively showing an improvement following surgery. Patients with proximal presurgical motor function of 2, 3, and 4 had an improved motor function in 73%, 77%, and 73% of the patients. Patients with distal presurgical motor function of 2, 3, and 4 had an improved motor function in 80%, 89%, and 70% of the patients. CONCLUSIONS: Most patients undergoing surgery for SMD have a modest improvement in motor function following surgery. The degree of improvement in most instances is less than 1 point on a 0 to 5 motor function scale. This is critical knowledge for a spinal surgeon when evaluating SMD patients with significant preoperative motor function deficits. These results aid spinal surgeons in setting expectations and evaluating the need for rapid spinal decompression. Elsevier 2023-07-02 /pmc/articles/PMC10345847/ /pubmed/37457395 http://dx.doi.org/10.1016/j.xnsj.2023.100240 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Studies
Okai, Bernard K.
Lipinski, Lindsay J.
Ghannam, Moleca M.
Fabiano, Andrew J.
Expected motor function change following decompressive surgery for spinal metastatic disease
title Expected motor function change following decompressive surgery for spinal metastatic disease
title_full Expected motor function change following decompressive surgery for spinal metastatic disease
title_fullStr Expected motor function change following decompressive surgery for spinal metastatic disease
title_full_unstemmed Expected motor function change following decompressive surgery for spinal metastatic disease
title_short Expected motor function change following decompressive surgery for spinal metastatic disease
title_sort expected motor function change following decompressive surgery for spinal metastatic disease
topic Clinical Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345847/
https://www.ncbi.nlm.nih.gov/pubmed/37457395
http://dx.doi.org/10.1016/j.xnsj.2023.100240
work_keys_str_mv AT okaibernardk expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease
AT lipinskilindsayj expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease
AT ghannammolecam expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease
AT fabianoandrewj expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease